Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel diseaseJ Schultheiss, Bas Oldenburg, Remi Mahmoud et al.|Alimentary Pharmacology & Therapeutics|2021Cited by 49
Su458 LOSS-OF-RESPONSE TO ANTI-TNFα CRITICALLY DEPENDS ON TREATMENT DURATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEJ Schultheiss, Bas Oldenburg, Remi Mahmoud et al.|Gastroenterology|2021Cited by 0
Mo1539: ANTI-TNF WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ENDOSCOPIC REMISSION: A PROSPECTIVE STUDYRemi Mahmoud, Bas Oldenburg, Edo Savelkoul et al.|Gastroenterology|2022Cited by 0
Tu1498: WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDYEdo Savelkoul, Frank Hoentjen, Remi Mahmoud et al.|Gastroenterology|2022Cited by 0
721: IMMUNOMODULATOR WITHDRAWAL FROM ANTI-TNF THERAPY IS NOT ASSOCIATED WITH LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASERemi Mahmoud, Bas Oldenburg, J Louwers et al.|Gastroenterology|2022Cited by 0